- ICH GCP
- US Clinical Trials Registry
- Researchers
- Poland
- Acute Myeloid Leukemia
Medical specialists from Poland tagged as investigators in clinical trials studying Acute Myeloid Leukemia
Total 11 results
-
Agnieszka Wierzbowska, Dr hab. n. med.Seen in:
- Lodz, Copernicus Memorial Hospital
Trials:- NCT02072811 (Principal Investigator)
Conditions: -
Aleksandra Wadolowska, MDSeen in:
- Gdańsk, Apteka Szpitalna
Trials:- NCT05319587 (Principal Investigator)
Conditions: -
Boguslaw Machalinski, MDSeen in:
- Szczecin, Samodzielny Publiczny Szpital Kliniczny nr 1 im. Prof. Tadeusza Sokołowskiego w Szczecinie, Klinika Hematologii z Oddziałem Transplantacji Szpiku, Szczecin
Trials:- NCT05319587 (Principal Investigator)
Conditions: -
Dominik Chraniuk, MDSeen in:
- Toruń, MICS Centrum Medyczne Torun
- Toruń, Nasz Lekarz Osrodek Badan Klinicznych
- Toruń, Nasz Lekarz Przychodnie Medyczne
Trials:- NCT05176691 (Principal Investigator)
- NCT03786926 (Principal Investigator)
- NCT04603495 (Principal Investigator)
- NCT06268574 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Waldenstrom Macroglobulinemia;
- Lymphoplasmacytic Lymphoma;
- NHL;
- DLBCL;
- Richter Syndrome;
- CLL/SLL;
- MCL;
- MZL;
- Lymphoma;
- Primary Myelofibrosis;
- Myelofibrosis;
- Post-polycythemia Vera Myelofibrosis;
- Post-essential Thrombocythemia Myelofibrosis;
- Acute Myeloid Leukemia (AML);
- High-risk Myelodysplastic Syndrome
-
Ewa Lech-Maranda, MDSeen in:
- Warsaw, Institute of Hematology and Transfusion Medicine
- Warsaw, Instytut Hematologii i Transfuzjologii
- Warsaw, Instytut Hematologii i Transfuzjologii, Klinika Hematologii, Warsaw
Trials:- NCT04021368 (Principal Investigator)
- NCT04442022 (Principal Investigator)
- NCT05319587 (Principal Investigator)
-
Jan Zaucha, MDSeen in:
- Gdańsk, Uniwersyteckie Centrum Kliniczne
Trials:- NCT04021368 (Principal Investigator)
Conditions: -
Janusz Halka, MD,PhDSeen in:
- Warmińsko-Mazurskie, Olsztyn, SP ZOZ MsWiA z Warminsko-Mazurksim Centrum Onkologii w Olsztynie Oddzial Kliniczny Hematologii
Trials:- NCT05319587 (Principal Investigator)
Conditions: -
Jaroslaw Dybko, MD, PhDSeen in:
- Dolnośląskie Województwo, Wrocław, Uniwersytecki Szpital Kliniczny Klinika Hematologii Nowotworow
Trials:- NCT05319587 (Principal Investigator)
Conditions: -
Krzysztof MądrySeen in:
- Mazowieckie Województwo, Warszawa, MTZ Clinical Research
Trials:- NCT06191263 (Principal Investigator)
- NCT06268574 (Principal Investigator)
-
Paweł Steckiewicz, MDSeen in:
- Świętokrzyskie, Kielce, Świętokrzyskie Centrum Onkologii, Klinika Hematologii i Transplantacji Szpiku
Trials:- NCT04021368 (Principal Investigator)
Conditions:
Clinical Trials on Acute Myeloid Leukemia
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States